Aryl hydrocarbon receptor nuclear translocator in human liver is regulated by miR-24

Toxicology and Applied Pharmacology

Volumn 260, Issue 3, 2012, Pages 222-231

  Oda, Yuki ^a   Nakajima, Miki ^a   Mohri, Takuya ^a   Takamiya, Masataka ^b   Aoki, Yasuhiro ^b   Fukami, Tatsuki ^a   Yokoi, Tsuyoshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

AhR; ARNT; CYP1A1; HIF1; MicroRNA; Post transcriptional regulation

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1BETA; MICRORNA; MIR 24; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA BINDING; RNA TRANSLATION;

ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOWN-REGULATION; HEP G2 CELLS; HUMANS; HYDROGEN PEROXIDE; LIVER; LIVER NEOPLASMS; MICRORNAS; REACTIVE OXYGEN SPECIES;

EID: 84859976379     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.02.012     Document Type: Article

References (32)

1. Arpiainen S., Lämsä V., Pelkonen O., Yim S.H., Gonzalez F.J., Hakkola J. Aryl hydrocarbon receptor nuclear translocator and upstream stimulatory factor regulate Cytochrome P450 2a5 transcription through a common E-box site. J. Mol. Biol. 2007, 369:640-652.
2. Azzouzi I., Moest H., Winkler J., Fauchère J.C., Gerber A.P., Wollscheid B., Stoffel M., Schmugge M., Speer O. MicroRNA-96 directly inhibits γ-globin expression in human erythropoiesis. PLoS One 2011, 6:e22838.
3. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
4. Betel D., Wilson M., Gabow A., Marks D.S., Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008, 36:149-153.
5. Chekulaeva M., Filipowicz W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr. Opin. Cell Biol. 2009, 21:452-460.
6. Chen P.S., Su J.L., Cha S.T., Tarn W.Y., Wang M.Y., Hsu H.C., Lin M.T., Chu C.Y., Hua K.T., Chen C.N., Kuo T.C., Chang K.J., Hsiao M., Chang Y.W., Chen J.S., Yang P.C., Kuo M.L. miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. J. Clin. Invest. 2011, 121:3442-3455.
7. Choi H., Chun Y.S., Kim S.W., Kim M.S., Park J.W. Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition. Mol. Pharmacol. 2006, 70:1664-1671.
8. Choi H., Chun Y.S., Shin Y.J., Ye S.K., Kim M.S., Park J.W. Curcumin attenuates cytochrome P450 induction in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin by ROS-dependently degrading AhR and ARNT. Cancer Sci. 2008, 99:2518-2524.
9. Davarinos N.A., Pollenz R.S. Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytosplasmic proteasome following nuclear export. J. Biol. Chem. 2000, 274:28708-28715.
10. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets. Genome Res. 2009, 19:92-105.
11. Gradin K., McGuire J., Wenger R.H., Kvietikova I., Whitelaw M.L., Toftgård R., Tora L., Gassmann M., Poellinger L. Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol. Cell. Biol. 1996, 16:5221-5231.
12. Gunton J.E., Kulkarni R.N., Yim S., Okada T., Hawthorne W.J., Tseng Y.H., Roberson R.S., Ricordi C., O'Connell P.J., Gonzalez F.J., Kahn C.R. Loss of ARNT/HIF1β mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 2005, 12:337-349.
13. Iwanari M., Nakajima M., Kizu R., Hayakawa K., Yokoi T. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences. Arch. Toxicol. 2002, 76:287-298.
14. Ke Q., Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol. 2006, 70:1469-1480.
15. Köhle C., Bock K.W. Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2. Biochem. Pharmacol. 2007, 73:1853-1862.
16. Lal A., Navarro F., Maher C.A., Maliszewski L.E., Yan N., O'Day E., Chowdhury D., Dykxhoorn D.M., Tsai P., Hofmann O., Becker K.G., Gorospe M., Hide W., Lieberman J. miR-24 inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol. Cell 2009, 35:10-625.
17. Lal A., Pan Y., Navarro F., Dykxhoorn D.M., Moreau L., Meire E., Bentwich Z., Lieberman J., Chowdhury D. miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat. Struct. Mol. Biol. 2009, 16:492-498.
18. Li N., Flynt A.S., Kim H.R., Solnica-Krezel L., Patton J.G. Dispatched Homolog 2 is targeted by miR-214 through a combination of three weak microRNA recognition sites. Nucleic Acids Res. 2008, 36:4277-4285.
19. Liang Y., Li W.W., Yang B.W., Tao Z.H., Sun H.C., Wang L., Xia J.L., Qin L.X., Tang Z.Y., Fan J., Wu W.Z. Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma. Int. J. Cancer 2012, 130:1745-1754.
20. Ma Q., Baldwin K.T. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway. J. Biol. Chem. 2000, 275:8432-8438.
21. Maltepe E., Schmidt J.V., Baunoch D., Bradfield C.A., Simon M.C. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997, 386:403-407.
22. Meng X.Z., Zheng T.S., Chen X., Wang J.B., Zhang W.H., Pan S.H., Jiang H.C., Liu L.X. microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells. J. Gastroenterol. Hepatol. 2011, 26:186-193.
23. Mohri T., Nakajima M., Fukami T., Takamiya M., Aoki Y., Yokoi T. Human CYP2E1 is regulated by miR-378. Biochem. Pharmacol. 2010, 79:1045-1052.
24. Mohri T., Nakajima M., Takagi S., Komagata S., Yokoi T. MicroRNA regulates human vitamin D receptor. Int. J. Cancer 2009, 125:1328-1333.
25. Qin W., Shi Y., Zhao B., Yao C., Jin L., Ma J., Jin Y. miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS One 2010, 5:e9429.
26. Ramadoss P., Marcus C., Perdew G.H. Role of the aryl hydrocarbon receptor in drug metabolism. Expert Opin. Drug Metab. Toxicol. 2005, 1:9-21.
27. Takagi S., Nakajima M., Kida K., Yamaura Y., Fukami T., Yokoi T. MicroRNAs regulate human hepatocyte nuclear factor 4α modulating the expression of metabolic enzymes and cell cycle. J. Biol. Chem. 2010, 285:4415-4422.
28. Takagi S., Nakajima M., Mohri T., Yokoi T. Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J. Biol. Chem. 2008, 283:9674-9680.
29. Tsuchiya Y., Nakajima M., Takagi S., Taniya T., Yokoi T. MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res. 2006, 66:9090-9098.
30. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C., Croce C.M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 2006, 103:2257-2261.
31. Yamakuchi M., Lotterman C.D., Bao C., Hruban R.H., Karim B., Mendell J.T., Huso D., Lowenstein C.J. P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc. Natl. Acad. Sci. USA 2010, 107:6334-6339.
32. Yamamoto J., Ihara K., Nakayama H., Hikino S., Satoh K., Kubo N., Iida T., Fujii Y., Hara T. Characteristic expression of aryl hydrocarbon receptor repressor gene in human tissues: organ-specific distribution and variable induction patterns in mononuclear cells. Life Sci. 2004, 74:1039-1049.